A longevity practice is not a DPC with extra labs. The panel is smaller, the price is higher, and the patient expects a report — not a visit summary. Here is how to build the model.
A longevity practice is not a direct primary care practice with extra labs. The panel is roughly a third the size. The membership price is four to five times higher. And the patient arrives expecting a report — a longitudinal picture of where their biomarkers have moved and what changes them — not a visit summary. Those differences change how the membership is structured, what belongs in it, and what to charge separately.
DPC practices are built around access: same-day appointments, direct messaging, a panel small enough that the physician actually knows the patient. A typical DPC panel runs from 400 to 800 patients. Longevity practices run under 200 — sometimes well under 100 at the premium end — because the work is more intensive per member, not more patients per day.
Functional medicine often starts from pathology: a patient arrives with a condition — autoimmune, metabolic, chronic fatigue — and the clinician works backward to root causes. Longevity medicine starts from optimization. The patient is often healthy by conventional measures and wants to stay that way, or to improve on metrics that standard care does not track. That framing changes who you attract, what you test, and how you explain value.
Concierge medicine is the closest structural cousin — traditional retainers bundle primary care with priority access, while longevity memberships are explicitly about biomarker tracking, trajectory, and report-style output. The patient is buying a program, not a doctor on call.
A DPC practice at 600 members billing an average of $100 per member per month generates $720,000 per year in membership revenue. A longevity practice at 200 members billing an average of $700 to $900 per member per month generates between $1.68 million and $2.16 million — with roughly a third the patient volume, fewer unscheduled visit slots consumed, and a visit cadence that is planned and structured rather than reactive.
The numbers work because the longevity patient is paying for results, not access. They are not calling on a Tuesday with a sinus infection. Visits are scheduled: a baseline evaluation, semi-annual reviews, and a year-end summary. Physician time per member is higher than in DPC, but unscheduled demand is lower. The practice runs on depth, not throughput.
The core mistake in longevity membership design is bundling everything. When comprehensive metabolic labs, hormone panels, advanced cardiac markers, and body composition assessments all sit inside the base fee, the membership price has to cover the worst-case consumer — the member who orders every test every quarter. That either prices most prospects out or leaves the practice underwater.
A workable structure layers three things:
Most longevity practices structure the year around two to four scheduled touchpoints. The annual baseline is the anchor: a comprehensive physical, a full biomarker panel, and a report that places current values in the context of trend lines and population benchmarks. Semi-annual or quarterly check-ins cover results interpretation and protocol adjustments.
Between visits, the patient expects asynchronous messaging for results questions, protocol changes, or new symptoms. That access is bounded: a longevity patient who can message their physician is not the same as a DPC patient who expects same-day urgent care. The visit structure and messaging policy are worth spelling out explicitly at enrollment.
The deliverable at the end of a review visit is the report — not a standard SOAP note. It is a document the patient reads and sometimes brings to a specialist. It shows where each biomarker sits today versus six months ago, and what the trajectory implies. Building note templates and snippets around that output changes how clinicians document and what the chart is actually for.
Standard EMR vital signs — blood pressure, weight, BMI — cover only a fraction of what a longevity practice tracks. A longevity panel might include grip strength, body fat percentage, waist-to-height ratio, or resting heart rate variability. Those measurements need to live somewhere in the chart and be visible in trend view over time, not scattered across individual visit notes where they resist comparison.
SigmaMD's custom vitals let a practice define exactly what it measures — with the name, unit, format, and allowed range the practice specifies — so those readings appear in the vitals flowsheet and trend view alongside standard vitals. The trends view plots any vital over time and can overlay a second vital for comparison. For a longevity practice, that is the mechanism for showing a member that their HbA1c has moved from one data point to the next over eighteen months, or that grip strength has improved alongside a change in resistance training protocol. That comparison is the whole story.
A longevity practice evaluates software on criteria most EMRs are not designed for. Membership billing has to handle multiple plan tiers at different price points, with different testing cadences attached to each. Billing cycles need flexibility — a quarterly option for a patient who cannot commit to an annual plan is different from a monthly auto-renew. Mid-cycle pricing adjustments and plan upgrades need to work without manual workarounds.
Documentation needs to support report-style output, not compliance-driven SOAP notes. An AI scribe that turns a visit into a draft is useful. Note templates and snippets built around a longevity review format — with trending vitals pulled in automatically via note variables — save time and produce consistent output the patient can actually read.
The chart itself needs to hold the longitudinal story. Lab results, vitals, medication changes, and body composition data should all be visible in one place and trackable over time — because the entire value proposition rests on showing that the trajectory is changing.
Most physician-run longevity practices maintain panels between 100 and 250 members, depending on visit depth and how much testing coordination the membership includes. Above 250, the reporting and tracking workload typically requires additional clinical support staff.
No. Longevity membership programs operate entirely outside insurance — the services are not covered and the visit structure does not map to billable encounter codes. The direct-pay model is not a workaround; it is the only structure that funds the time the work actually takes.
Functional medicine typically starts from a condition or symptom pattern and uses root-cause investigation to address it. Longevity medicine starts from a healthy baseline and uses optimization protocols to extend healthspan. The patient intake differs: longevity practices attract patients who consider themselves well; functional practices often attract patients who have not found answers in conventional care.
Yes. The longevity tier sits above the standard DPC membership, is capped at a small number of members, and carries a higher fee covering the additional testing and reporting work. Keep the tiers operationally separate — otherwise longevity members end up in the same scheduling queue as DPC patients, and the reporting work becomes unprofitable.
SigmaMD is built for direct-care practices that run on membership billing and longitudinal patient relationships — including practices that manage multiple tiers, track custom biomarkers over time, and need documentation built around the reports patients actually read. If you are designing a longevity membership or adding a longevity tier to an existing practice, book a demo to see how the platform handles it.